Stereoisomeric Medium-Ring R,R′-Dihydroxy Cycloalkanones
J ) 5.2, 2.3 Hz, 1 H), 4.48 (dd, J ) 5.8, 2.2 Hz, 1 H), 3.59 (s,
1 H), 2.96-2.90 (m, 1 H), 2.01-1.34 (series of m, 9 H), 0.95 (s,
9 H), 0.10 (s, 3 H), 0.07 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ
219.6, 77.7, 74.6, 39.4, 27.6, 26.0 (3C), 24.8, 21.9, 19.1, 18.3,
-4.4, -4.9; ES HRMS m/z (M + Na)+ calcd 295.1699, obsd
295.1682.
(2.25 mL) was stirred at rt for 12 h and quenched with
saturated NaHCO3 solution. The aqueous layer was extracted
with ether (3 × 50 mL), and the combined organic phases were
dried and purified.
Chromatography of the residue on silica gel (elution with
10:1 hexane/ethyl acetate) gave 33 as a colorless oil (46 mg,
1
92%): IR (neat, cm-1) 1707, 1464, 1253; H NMR (300 MHz,
3-Ben zyloxy-1,2-cycloocta n ed ion e (29). A solution of 28
(500 mg, 2.0 mmol) in dry CH2Cl2 (10 mL) was added to a
stirred suspension of the Dess-Martin periodinane (1.27 g,
3.0 mmol) in 30 mL of the same solvent. The reaction mixture
was stirred at rt for 2 h and quenched with water. The
separated aqueous phase was extracted with CH2Cl2 (3×), and
the combined organic solutions were washed with brine, dried,
and evaporated. The residue was chromatographed on silica
gel (elution with 10% ethyl acetate in hexane) to yield 490 mg
CDCl3) δ 4.66 (dd, J ) 8.8, 4.9 Hz, 1 H), 2.94-2.80 (m, 1 H),
2.40-2.34 (m, 1 H), 2.09-1.41 (series of m, 8 H), 0.94 (s, 9 H),
0.15 (s, 3 H), 0.08 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 210.6,
208.5, 75.9, 40.0, 31.9, 27.3, 26.1 (3C), 21.2, 20.3, 18.7, -4.4,
-5.0; ES HRMS m/z (M + Na)+ calcd 293.1543, obsd 293.1532.
B. With th e Dess-Ma r tin P er iod in a n e. A solution of 26
(50 mg, 1.82 mmol) and the Dess-Martin periodinane (924
mg, 2.18 mmol) in 8:1 THF/DMSO (2.25 mL) was stirred at rt
for 4 h, quenched with saturated NaHCO3 solution, and
extracted with ether (3 × 50 mL). The combined organic phases
were dried and concentrated, and the residue was chromato-
graphed on silica gel (elution with 10:1 hexane/ethyl acetate)
to give 33 as a colorless oil (47 mg, 90%), identical in all
respects with the material prepared above.
(99%) of 29 as a yellow solid: mp 46-48 °C; IR (neat, cm-1
)
1704, 1464, 1454; 1H NMR (300 MHz, CDCl3) δ 7.39-7.27 (m,
5 H), 4.77 (d, J ) 11.6 Hz, 1 H), 4.43 (d, J ) 11.6 Hz, 1 H),
4.39-4.35 (m, 1 H), 2.88 (ddd, J ) 19.5, 11.7, 3.8 Hz, 1 H),
2.37 (ddd, J ) 19.1, 13.5, 3.3 Hz, 1 H), 2.12-2.03 (m, 1 H),
2.02-1.71 (m, 4 H), 1.66-1.57 (m, 2 H), 1.49-1.35 (m, 1 H);
13C NMR (75 MHz, CDCl3) δ 209.5, 207.7, 137.4, 128.5 (2C),
128.0, 127.9 (2C), 81.2, 72.3, 39.0, 29.0, 27.4, 20.6, 19.9; ES
HRMS m/z (M + Na)+ calcd 269.1148, obsd 269.1138.
Red u ction of 33. A. With Zin c a n d Sa tu r a ted Am -
m on iu m Ch lor id e. A solution of 33 (70 mg, 0.29 mmol) in
THF (0.7 mL) containing ammonium chloride (0.7 mg) was
treated with zinc dust (36 mg, 0.57 mmol) in one portion. The
reaction mixture was stirred for 2 h, quenched with saturated
NaHCO3 solution, and extracted with ether (3 × 50 mL). The
combined organic phases were dried, concentrated, and sub-
jected to chromatograpy on silica gel. Elution with 20:1
hexanes/ethyl acetate furnished 42 mg (60%) of 35 as a
yellowish oil: IR (neat, cm-1) 3487, 1702, 1472; 1H NMR (300
MHz, CDCl3) δ 4.35 (d, J ) 2.9 Hz, 1 H), 4.30 (dt, J ) 9.2, 3.1
Hz, 1 H), 2.59-2.51 (m, 2 H), 2.01-1.89 (series of m, 5 H),
0.94 (s, 9 H), 0.15 (s, 3 H), 0.12 (s, 3 H); 13C NMR (75 MHz,
CDCl3) δ 213.0, 79.5, 73.9, 40.1, 31.2, 27.9 (3C), 24.4, 20.5, 18.5,
-4.3, -4.4; ES HRMS m/z (M + Na)+ calcd 295.1699, obsd
295.1713.
cis-3-Ben zyloxy-2-h yd r oxycycloocta n on e (30). A solu-
tion of 29 (50 mg, 0.20 mmol) in 1 mL of a 1:1 mixture of
saturated NH4Cl and THF was treated with zinc dust (26 mg,
0.4 mmol), stirred vigorously at rt for 2 h, and diluted with
CH2Cl2 and water. The separated aqueous layer was extracted
with CH2Cl2, and the combined organic phases were dried and
concentrated. Purification of the residue by chromatography
on silica gel (elution with 10% ethyl acetate in hexane)
furnished 30 mg (60%) of 30 as a colorless oil: IR (neat, cm-1
)
3466, 1703, 1465; 1H NMR (300 MHz, CDCl3) δ 7.39-7.27 (m,
5 H), 4.65 (s, 2 H), 4.45 (d, J ) 2.5 Hz, 1 H), 4.09 (ddd, J )
13.2, 6.6, 2.8 Hz,1 H), 3.55 (br s, 1 H), 2.50-2.45 (m, 2 H),
2.00-1.83 (m, 3 H), 1.80-1.49 (m, 3 H), 1.43-1.30 (m, 1 H),
1.16-1.02 (m, 1 H); 13C NMR (75 MHz, CDCl3) δ 213.0, 138.2,
128.4 (2C), 127.73, 127.68 (2C), 77.7, 77.6, 71.0, 38.6, 27.9, 26.9,
26.6, 21.6; ES HRMS m/z (M + Na)+ calcd 271.1305, obsd
271.1303.
Desilyla tion of 34. To a solution of 34 (10 mg, 0.037 mmol)
in THF (1 mL) was added 30 µL (0.039 mmol) of 1 M TBAF in
the same solvent. After 15 min at rt, the reaction mixture was
concentrated in vacuo, and the residue was chromatographed
on silica gel. Elution with 50% hexane in ethyl acetate afforded
2.8 mg (48%) of 36 and 1.4 mg (24%) of 31, both as colorless
oils.
cis-2,3-Dih yd r oxycycloocta n on e (31). A solution of 30
(10 mg, 0.04 mmol) in ethanol (1.5 mL) was admixed with 10%
palladium on carbon (5 mg), and the mixture was stirred for
2 h under 1 atm of hydrogen. The predescribed workup
For 36: white solid; mp 120-121 °C; IR (neat, cm-1) 3693,
afforded 6 mg (99%) of 31 as a colorless oil: IR (neat, cm-1
)
1
3398, 1702, 1059; 1H NMR (300 MHz, CDCl3) δ 4.49-4.39 (m,
1 H), 4.44 (d, J ) 3.5 Hz, 1 H), 2.67 (ddd, J ) 14.3, 10.7, 3.6
Hz, 1 H), 2.50-2.46 (m, 1 H), 2.00-1.68 (series of m, 6 H),
1.50-1.41 (m, 1 H), 1.03-0.96 (m, 1 H); 13C NMR (75 MHz,
CDCl3) δ 213.1, 79.6, 70.9, 38.6, 31.6, 28.1, 26.5, 22.6; ES
HRMS m/z (M + Na)+ calcd 181.0835, obsd 181.0839.
1705, 1246; H NMR (300 MHz, CDCl3) δ 4.41 (dd, J ) 7.7,
3.7 Hz, 2 H), 3.26 (s, 2 H), 2.33-2.27 (m, 2 H), 1.97-1.90 (m,
2 H), 1.84-1.66 (m, 4 H), 1.48-1.40 (m, 2 H); 13C NMR (75
MHz, CDCl3) δ 218.2, 74.1 (2C), 33.4 (2C), 24.6, 21.9 (2C); ES
HRMS m/z (M + Na)+ calcd 181.0835, obsd 181.0829.
Nysted Hom ologa tion of 26. Into a flame-dried flask
equipped with a stirring bar and a N2-filled balloon was placed
a 20% suspension of the Nysted reagent in THF (14.7 g, 6.45
mmol) and additional THF (12 mL). The suspension was cooled
to 0 °C, and neat titanium tetrachloride (0.71 mL, 6.45 mmol)
was introduced dropwise followed by the addition of 26 (1.17
g, 4.3 mmol) dissolved in THF (8 mL). The reaction mixture
was stirred at rt for 24 h, quenched with 10% HCl (100 mL),
transferred to an addition funnel, and extracted with ether (3
× 100 mL). The combined organic layers were dried and
evaporated to leave a residue that was purified by chroma-
tography on silica gel. Elution with 20:1 hexane/ethyl acetate
gave 48 mg (42%) of 37 and 157 mg (14%) of 38, both as
colorless oils.
Bor oh yd r id e Red u ction of 31. A solution of 31 (2.6 mg,
0.015 mmol) in methanol (0.5 mL) was cooled to 0 °C, treated
with sodium borohydride (0.2 mg, 0.015 mmol), and stirred
for 10 min prior to being quenched with saturated NaHCO3
solution. The separated aqueous layer was extracted with
ether (3 × 15 mL), and the combined organic phases were dried
and concentrated. Chromatographic purification of the residue
on silica gel (elution with 50% hexane/ethyl acetate) gave an
inseparable 1:1 mixture of 24 and 32 as recognized by high-
field 1H NMR analysis.
Pure triol 32 was independently prepared by comparable
reduction of 34 followed by desilylation: white solid; mp 84-
1
85 °C; IR (neat, cm-1) 3614, 1477, 1236; H NMR (300 MHz,
For 37: IR (neat, cm-1) 3581, 1462, 1253; 1H NMR (300
MHz, CDCl3) δ 5.18 (s, 1 H), 5.18 (d, J ) 0.6 Hz, 1 H), 4.48
(dd, J ) 9.2, 4.7 Hz, 1 H), 4.27 (dd, J ) 8.4, 4. Hz, 1 H), 2.04-
1.99 (m,1 H), 1.83-1.38 (m, 9 H), 0.91 (s, 9 H), 0.08 (s, 3 H),
0.05 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 157.0, 113.5, 73.6,
71.7, 36.8, 35.3, 26.2 (3C), 26.1, 22.4, 21.7, 18.4, -4.2, -4.4;
ES HRMS m/z (M + Na)+ calcd 293.1907, obsd 293.1901.
CDCl3) δ 4.03-3.99 (m, 2 H), 3.96 (d, J ) 2.5 Hz, 1 H), 2.37 (s,
OH), 2.10-2.04 (m, 2 H), 1.92-1.80 (m, 4 H), 1.71-1.34 (m, 4
H); 13C NMR (75 MHz, CDCl3) δ 77.6, 76.1 (2C), 32.6 (2C),
29.1, 22.9 (2C); ES HRMS m/z (M + Na)+ calcd 183.0991, obsd
183.0993.
Oxid a tion of 26. A. With IBX. A solution of 26 (50.0 mg,
1.82 mmol) and IBX (608 mg, 2.18 mmol) in 8:1 THF/DMSO
J . Org. Chem, Vol. 69, No. 7, 2004 2459